By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Eyenovia Inc is a clinical-stage biopharmaceutical company operating in the US. It is engaged in developing a pipeline of ophthalmology products utilizing its patented piezo-print technology to deliver micro-therapeutics for the treatment of prominent eye diseases, such as glaucoma, dry eyes, allergic eye disease and many others. The pipeline products of the company are MicroProst for chronic angle closure glaucoma, MicroStat for pharmacologic mydriasis, MicroTears for dry eye and MicroPine for myopia.

Contact Information

Website: www.eyenoviabio.com
Email: admin@eyenoviabio.com
Main Phone: +1 917 289-1117
Address: 295 Madison Avenue
Address 2: Suite 2400
State: NY
City / Town: New York
Country: US
Postal Code: 10017

Issuer Information

Exchange: NSC
CEO: Tsontcho Ianchulev
Employees: 29
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A